Non-Diabetic Nephropathy, When Should We Think About It?

Youssouf Belazzouz*

Received: June 06, 2019;   Published: June 11, 2019

DOI: 10.32474/JUNS.2019.01.000126

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Diabetic nephropathy is the result of pathophysiological mechanisms whose best knowledge has offered new therapeutic possibilities and a better life expectancy for both type 1 and type 2 diabetes. Nevertheless, the diabetic kidney may be the seat of other lesions. This is due to diabetics whose positive diagnosis is based on renal biopsy, which is certainly an invasive means but will allow etiological therapeutic management other than glycemic control. diabetic nephropathy is a chronic pathology which therefore requires non-invasive monitoring means that will allow us not only to determine the rate of progression of diabetic kidney disease but also to indicate screening for previously undiagnosed non-diabetic renal lesion. for this reason, biological and morphological means are necessary whose cost-benefit ratio is necessary before their standardization by targeting a certain diabetic population thus allowing to act at an earlier stage before the installation of irreversible lesions.

Abstract| Introduction| Conclusion| References|